Dr Agarwals Healthcare IPO Allotment Status Subscription Status And Details Visionarydaily

Table of Contents

Dr Agarwals Healthcare IPO allotment status Subscription Status and promoters holding Details

Dr Agarwals Healthcare has launched an initial public offering (IPO) valued at ₹3,027.26 crores. This offering includes a fresh issue of 0.75 crore shares totaling ₹300.00 crores, alongside an offer for sale of 6.78 crore shares amounting to ₹2,727.26 crores.

The IPO bidding commenced on January 29, 2025, and concluded on January 31, 2025. Allotments are anticipated to be confirmed on Monday, February 3, 2025, with shares set to debut on the BSE and NSE on Wednesday, February 5, 2025.

The price band for the Dr. Agarwal’s Healthcare IPO is established at ₹382 to ₹402 per share, and investors must apply for a minimum of 35 shares. For retail investors, the minimum investment required is ₹14,070. Small and Non-Institutional Investors (sNII) need to apply for at least 15 lots (525 shares), which amounts to ₹2,11,050, while the basic requirement for large Non-Institutional Investors (bNII) is 72 lots (2,520 shares), totaling ₹10,13,040.

Subscription Details

Category	Subscription (times)	Shares Offered	Shares Bid For
QIB	2.27	1,45,19,200	3,29,54,425
NII	0.17	1,08,89,400	18,63,400
bNII (bids above ₹10L)	0.12	72,59,600	8,80,670
sNII (bids below ₹10L)	0.26	36,29,800	9,57,880
Retail	0.3	2,54,08,599	75,59,440
Employee	0.21	15,79,399	3,31,100
Others	0.31	11,29,574	3,48,425
Total	0.8	5,35,26,172	4,30,56,790

Total Application : 2,27,023

Date: January 31, 2025, (Day 3 by 11.29 AM)

Dr Agarwals Healthcare IPO allotment status has seen a subscription rate of 0.46 times as of January 31, 2025, at 11:29:51 AM on its third day. In detail, the retail category subscribed at 0.29 times, the Qualified Institutional Buyers (QIB) category at 1.01 times, and the Non-Institutional Investors (NII) category at 0.17 times.

Date: January 30, 2025 (Day 2)

January 30, 2025, the subscription status for Dr. Agarwal’s Healthcare IPO stands at 0.08 times, according to NSE data. Retail investors are leading with a subscription rate of 0.13 times. Meanwhile, Non-Institutional Investors (NII) have subscribed at a rate of 0.06 times. Qualified Institutional Buyers (QIBs) demonstrated the least engagement, having placed bids for only 18,375 shares out of the 1,45,19,200 shares allocated to them. The employee quota is subscribed at 0.09 times, while shareholders contribute to a subscription rate of 0.15 times.

Date: January 29, 2025 (Day 1)

On January 29, 2025, the Dr. Agarwal’s Healthcare IPO recorded a subscription of 0.02 times by 10:40 a.m. based on BSE data. In this round, retail investors again took the lead with a subscription of 0.03 times. However, Qualified Institutional Buyers had no subscriptions logged, and Non-Institutional Investors indicated a subscription rate of 0.05 times.

Overview of Dr. Agarwal’s Health Care Limited

Founded in 2010, Dr. Agarwal’s Health Care Limited specializes in a wide array of eye care services. Their offerings range from cataract and refractive surgeries to consultations, diagnoses, and non-surgical treatments. They also provide a selection of optical products, including contact lenses and pharmaceuticals related to eye care.

By September 30, 2024, the company had 737 doctors providing care across its facilities, serving 2.13 million patients and performing 220,523 surgeries. In the six months leading up to this date, the company served 1.15 million patients and conducted 140,787 surgeries.

Service Highlights

– Cataract Surgeries: Offering advanced surgical options including small incision techniques, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments.

Promoter Stakeholders at Dr. Agarwal’s Healthcare

The Promoters of Dr. Agarwal’s Healthcare include Dr. Amar Agarwal, Dr. Athiya Agarwal, Dr. Adil Agarwal, Dr. Anosh Agarwal, Dr. Ashvin Agarwal, Dr. Ashar Agarwal, along with various family trusts related to these individuals, as well as Dr. Agarwal’s Eye Institute and its private counterparts.

Dr. Agarwals Healthcare has successfully secured Rs 875.51 crore through its IPO from anchor investors. The bidding date for the anchor investors is set for January 28, 2025. Below is the list of the anchor investors participating in the IPO.

Share Holding	Percentage
Pre-Issue	37.72%
Post-Issue	32.5%

Financial Overview of Dr. Agarwal’s Health Care Limited

Period Ended	30 Sep 2024	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets (₹ Cr)	3,393.41	2,752.82	1,825.17	1,026.13
Revenue (₹ Cr)	837.94	1,376.45	1,031.49	713.78
Profit After Tax (₹ Cr)	39.56	95.05	103.23	43.16
Net Worth (₹ Cr)	1,502.67	1,337.68	627.83	212.34
Reserves & Surplus (₹ Cr)	1,509.11	1,365.86	652.63	236.27
Total Borrowing (₹ Cr)	373.68	387.79	356.18	290.18

Dr Agarwals Healthcare IPO allotment status

Grey Market Premium (GMP) Insights

As reported by Business Standard, the Grey Market Premium (GMP) for Dr. Agarwal’s Healthcare IPO was noted at ₹5 as of January 31, 2025, at 10:20 AM. This reflects a premium of 1.24% over the upper end of the issue price, with an estimated listing price projected around ₹407.

What is Grey Market Stock?

Grey market stock refers to shares that are being traded unofficially by individuals before they are officially listed in an Initial Public Offering (IPO). When a company’s shares are available for trading through brokers prior to their official release, they fall under the category of grey market stock.

Typically, a small group of traders manages the grey market, and transactions are conducted based on mutual trust. In India, trading in grey market stocks is considered legal but unofficial. These trades cannot be finalized until the official trading begins.

What is Grey Market Premium?

The grey market premium is the price at which IPO shares are being traded in the grey market. This reflects the buy and sell activity around a company’s upcoming IPO outside of the formal stock exchange. The current grey market premium offers insight into how the IPO is likely to perform on its listing day.

For example:

Let’s say Stock Y has an issue price of Rs. 100, and the grey market premium stands at Rs. 300. This indicates that investors are willing to buy shares of Company Y for Rs. 400 (100 + 300).

Disclaimer:

Dr Agarwals Healthcare IPO allotment status Subscription Status and Details

Content shared on or through our digital media channels are for information and education purposes only and should not be treated as investment or trading advice. Please do your own analysis or take independent professional financial advice before making any investments based on your own personal circumstances. Investment in securities are subject to market risks, please carry out your due diligence before investing. And last but not the least, past performance is not indicative of future returns.

The IPO Grey Market Premium for Dr. Agarwal’s Health Care IPO is only accurate as of the date noted in the header. Please be aware that we do not engage in the buying or selling of IPO forms in the Grey Market.

The Kostak Rate refers to the amount one can receive by selling their IPO application to another party in an off-market transaction prior to allotment or listing.